UKRTN

Providing Clinical Trials Expertise.
[email protected]

[AKTN @Kidney_Trials]

We’ve had an excellent couple of days with the NZ CRA team and discussing rolling out the PHOSPHATE and TEACH-PD trials across NZ.

[UKRTN @ukrtn]

Very excited to announce that @Prof_Nick_James will be speaking at the @ukrtn trials session at @UKKW2020! Looking forward to learning from the extraordinary #STAMPEDE trial experience.

[UKRTN @ukrtn]

The next @ukrtn meeting will be held on 11th May. Find out more about @ukrtn below, and consider submitting your trial proposal for independent review and advice.
https://t.co/CE0UirGxiz

[UKRTN @ukrtn]

@willkidney @fjcaskey @drpaddymark @JMSWason @DavidCWheeler2 @Thomas_Hiemstra @CharlieFerro @RichardHaynes3 For discussion, design advice or possible endorsement contact @Thomas_Hiemstra or email [email protected] 2/2

[UKRTN @ukrtn]

The next #UKRTN meeting is on 23rd Sept (London). Amazing opportunity for informal discussion of your new #trial proposals with #UKKRC experts including @willkidney @fjcaskey @drpaddymark @JMSWason @DavidCWheeler2 @Thomas_Hiemstra @charlieferro @RichardHaynes3 and many others 1/2

[thomas . @Thomas_Hiemstra]

#UKKW2019

[Ed Wilson 🇪🇺 @EdCFWilson]

@S_brimble @Thomas_Hiemstra @RidingAlex @johnasayer @athattersley @ukrtn @MattLanktree That would be my argument- what is the actual benefit to patients from genotyping? Would only be cost-eff if there is a cost-eff tx available. If can use genotyping to target tx then there is potential to improve CEness of an expensive tx by avoiding px who won't respond.

[Dr Katie Fielding RN, PhD @katiefielding8]

@ukrtn really useful and practical sessions on running clinical trials and interesting to hear about trials within the UK. Learnt loads and enjoyed hearing about patient involvement - thank you #UKKW2019 @Thomas_Hiemstra @fjcaskey

[UKRTN @ukrtn]

Brilliant series of talks in the @ukrtn #UKKW2019 #trials session from @RichardHaynes3 Claire Corps @Thomas_Hiemstra @NatalieStaplin @fjcaskey 👏

[UKRTN @ukrtn]

#UKKW2019 @NatalieStaplin giving a brilliant talk on trials statistics

[thomas . @Thomas_Hiemstra]

.@ukrtn @UKKW2019 @NatalieStaplin making complex concepts understandable - loving the p-value breakdown! 😂

[Fergus Caskey @fjcaskey]

@Thomas_Hiemstra @ukrtn @UKKW2019 @NatalieStaplin Followed by a useful suggestion for how we should really use p-values! #UKKW2019

[SIMPLIFIED trial @SIMPLIFIE_D]

Come and say hello at the SIMPLIFIED poster and Trial Meeting today at #UKKW2019 😊
@UKRenalResearch
@Kidney_Research
@ukrtn
#UKKRC

[thomas . @Thomas_Hiemstra]

Claire Corps #UKKW2019 @ukrtn ‘remember the importance of feedback to trial participants on the outcome of the trial.’ This is something often done very poorly!

[UKRTN @ukrtn]

Great start to #UKKW2019 with joint NIHR-UKKRC-Industry meeting. Much opportunity for collaboration. Some things done well but no room for complacency. @NIHRresearch @Kidney_Research @UKRenalResearch

[Prof Liz B 🇬🇧🇮🇱🇺🇦🇵🇸 @kidneydoc101]

#UKKW2019 @Thomas_Hiemstra highlighting work of @ukrtn in early translation studies as well as later phase #UKKW2019

[UKRTN @ukrtn]

The next @ukrtn meeting is in London on May 20th. Contact @Thomas_Hiemstra with proposals for the next #DreamRCT #UKKRC @RenalAssoc @BritishRenalSoc @UKRenalResearch @Kidney_Research

[UKRTN @ukrtn]

Looking forward to an exciting 2019. We start with the first UKRTN meeting of the New Year on 21st January. Get your proposals in by contacting @Thomas_Hiemstra or mailing [email protected]

[thomas . @Thomas_Hiemstra]

Another edition of ISN-ACT's excellent #nephrology #trials review https://t.co/HayQstpndn